In market activity today, Biosyent Inc shares opened at $8.60 and closed at $8.40. prices ranged from a low of $8.40 to a high of $8.60.

The price decreased -1.18% from the previous day's close of $8.50.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 4967.23, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37986.40 and the Nasdaq Composite closed nasdaq_percentage_change% at 15282.01.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 3,736 on 19 total trades. On average, Biosyent Inc has traded 3,348 shares over the last 5-days and 5,213 year-to-date.

Trading across the entire TSX-V saw 3,754 price advancers against 1,430 declines and 130 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 8.39 percent in the last 52 weeks, while they have eased -8.89% since the start of 2024.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $98.68 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 1.00 analysts, Biosyent Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..